NERV

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total common shares outstanding 6.99 M6.99 M6.99 M6.99 M6.99 M — Enterprise value -7.86 M-5.83 M-5.4 M-3.22 M2.43 M -12.01 M Price to earnings ratio -6.6811.692.071.16-1.14 13.79 Price to sales ratio 0.76—0.480.49-628.37 — Price to cash flow ratio 0.270.860.160.20.37 1.59 Price to book ratio -0.15-0.65-0.11-0.12-0.13 -1.01 Enterprise value to EBITDA ratio ————— — Return on assets % 0.53-0.12-0.11-0.11-0.1 -0.43 Return on equity % -1.040.170.130.10.08 0.48 Return on invested capital % ————— — Gross margin % 100100100100100 400 Operating margin % -16.43-43.55 K46.6 K15.98 K45.54 K 64.56 K EBITDA margin % ————— — Net margin % 84.7-41.14 K44.81 K15.44 K43.93 K 63.03 K Quick ratio ————— — Current ratio 6.237.859.216.154.87 28.08 Inventory turnover ————— — Asset turnover 0.60-0-0-0 -0 Debt to assets ratio ————— — Debt to equity ratio ————— — Long term debt to total assets ratio ————— — Long term debt to total equity ratio ————— — Operating cash flow per share 3.234.490.540.260.38 5.68 EBIT per share ————— — EBITDA per share ————— — Total debt per share ————— — Cash per share 3.52.822.282.011.62 8.74 Net current asset value per share 3.692.942.372.051.72 9.08 Tangible book value per share -4.83-5.36-5.82-6.21-6.53 -23.91 Working capital per share 3.12.572.111.721.37 7.76 Book value per share -2.86-3.39-3.85-4.24-4.57 -16.05